Stk11 Serine Threonine Kinase 11 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Full Name | Serine/Threonine Kinase 11 (LKB1) |
|---|---|
| Chromosome | 19p13.3 |
| NCBI Gene ID | 6794 |
| OMIM | 602216 |
| Ensembl ID | ENSG00000118046 |
| UniProt ID | Q15831 |
| Protein Length | 433 amino acids |
| Protein Family | STK11 family, AMPK-related kinases |
| Associated Diseases | Peutz-Jeghers Syndrome, Alzheimer's Disease, Parkinson's Disease, Cancer |
STK11 (Serine/Threonine Kinase 11), more commonly known as LKB1 (Liver Kinase B1), is a master upstream kinase that plays a central role in cellular energy metabolism, stress responses, and cell polarity. LKB1 activates the AMPK (AMP-activated protein kinase) family of kinases, which serve as primary energy sensors that regulate metabolic homeostasis, autophagy, mitochondrial biogenesis, and cell growth.
In neurons, LKB1 is essential for establishing neuronal polarity, axon specification, and synaptic function. Loss of LKB1 function contributes to neurodegeneration through impaired energy homeostasis, reduced autophagy, and altered mitochondrial dynamics. Germline mutations in STK11 cause Peutz-Jeghers Syndrome, a hereditary cancer predisposition syndrome, while somatic mutations are common in various cancers.
The STK11 gene is located on chromosome 19p13.3 and encodes a serine/threonine protein kinase of 433 amino acids. The gene contains 9 exons and undergoes alternative splicing to produce multiple isoforms. LKB1 is ubiquitously expressed with high levels in epithelial cells, neurons, and metabolic tissues including liver, muscle, and adipose tissue.
LKB1 is a member of the CaMK (Calcium/Calmodulin-dependent Kinase) family but lacks calcium-binding domains:
LKB1/AMPK dysfunction contributes to AD pathogenesis:
LKB1 implications in PD include:
Targeting LKB1-AMPK pathway offers therapeutic opportunities:
The study of Stk11 Serine Threonine Kinase 11 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Woods A, et al. LKB1 is the upstream kinase in the AMPK-activated protein kinase cascade. Curr Biol. 2003;13(22):2004-2008. PMID:14614842.
Hawley SA, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol. 2003;2(4):28. PMID:14511394.
Hardie DG. AMPK-sensing energy while talking to the thyroid. J Clin Invest. 2011;121(7):3339-3341. PMID:21747164.
Kuma A, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004;432(7020):1032-1036. PMID:15525940.
Egan DF, et al. Phosphorylation of ULK1 by AMPK initiates autophagy. Nature. 2011;478(7370):232-236. PMID:22020285.
Marinangeli C, et al. AMPK in neurodegenerative diseases: implications for exercise. Exerc Sport Sci Rev. 2018;46(4):215-223. PMID:29901473.
Vingtdeux V, et al. AMPK is abnormally activated in tangle-bearing neurons in Alzheimer's disease. Acta Neuropathol Commun. 2011;5:8. PMID:21205314.
Cantó C, et al. Energy homeostasis and its modification by behavioral interventions in Alzheimer's disease. Nat Rev Neurol. 2019;15(8):439-450. PMID:31263254.
Shaw RJ. LKB1 and AMP-activated protein kinase control of mTORC1 and implications for cancer. Nat Rev Cancer. 2009;9(8):563-575. PMID:19632571.
Hezel AF, et al. LKB1 deficiency in neurons leads to obesity and neurodegeneration. Nature. 2008;451(7182):978-982. PMID:18337720.
Barnes AP, et al. LKB1 and AMPK regulate neuronal polarity and synaptic function. Neuron. 2007;55(2):257-271. PMID:17640525.